About the journal
Journal of Oncology Pharmacy Practice is a journal published by SAGE Publishing in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1078-1552 · 1477-092X
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://opp.sagepub.com/
Index listings
- MEDLINE · 2005-01-01
- PUBMED · 2011-02-14
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3490
Last recorded publication year
2026
h-index
55
i10-index
933
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 98%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9511372
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Safe Handling of Antineoplastic Drugs
- Safe Handling of Antineoplastic Drugs
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Pharmaceutical Practices and Patient Outcomes
- Chemotherapy-related skin toxicity
- Pharmaceutical Practices and Patient Outcomes
- Chemotherapy-related skin toxicity
Show all subjects (50)
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Patient Safety and Medication Errors
- Lung Cancer Treatments and Mutations
- Patient Safety and Medication Errors
- Acute Lymphoblastic Leukemia research
- Lung Cancer Treatments and Mutations
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Chemotherapy-induced organ toxicity mitigation
- Chemotherapy-induced organ toxicity mitigation
- Chemotherapy-induced cardiotoxicity and mitigation
- Chemotherapy-induced cardiotoxicity and mitigation
- HER2/EGFR in Cancer Research
- Drug-Induced Adverse Reactions
- HER2/EGFR in Cancer Research
- Drug-Induced Adverse Reactions
- Nausea and vomiting management
- Lymphoma Diagnosis and Treatment
- Nausea and vomiting management
- Lymphoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ